Read Gene Spolka Akcyjna Logo

Read Gene Spolka Akcyjna

RDG | WAR

Overview

Corporate Details

ISIN(s):
PLRADGN00014 (+1 more)
LEI:
2594003D7O7NDUV8GE29
Country:
Poland
Address:
Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
Sector:
Health Care
Industry:
Health Care Technology

Description

Read Gene Spolka Akcyjna is at the forefront of innovative genetics, focusing on the commercialization of groundbreaking methods for detecting, preventing, and treating various forms of malignant tumors. Our cutting-edge DNA testing offers precise profiling to identify individuals’ genetic predispositions to cancer, enabling earlier treatment interventions. We collaborate closely with the International Center for Hereditary Cancers at the Pomeranian Medical University, leveraging the expertise of renowned scientists led by Prof. Jan Lubiński. Committed to scientific advancement and patient care, we continually strive to set new standards in genetic testing and personalized medicine. Join us in our mission to transform cancer care through innovation and research.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-03-25 10:54
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.0 KB
2024-03-25 10:51
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-11-22 16:45
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-11-16 17:31
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-10-26 16:35
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:11
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.4 KB
2023-08-07 12:08
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.8 KB
2023-08-07 12:04
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:01
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-02 13:48
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-08-02 13:45
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:06
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:04
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na ZWZ READ-GENE S.A. w…
Polish 584 bytes
2023-06-29 13:27
Directors' Dealings
powiadomienie_o_transakcjach_-_zmiana.pdf
Polish 11.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Physitrack Logo Physitrack United Kingdom PTRK
PMD Device Solutions AB Logo PMD Device Solutions AB Sweden PMDS
Proacta Spolka Akcyjna Logo Proacta Spolka Akcyjna Poland PAC
RaySearch Laboratories Logo RaySearch Laboratories Sweden RAY
RED ROCK RESOURCES PLC Logo RED ROCK RESOURCES PLC United Kingdom RRR
Revenio Group Oyj Logo Revenio Group Oyj Finland REG1V
SHL TeleMedicine Ltd. Logo SHL TeleMedicine Ltd. Israel SHLTN
Telemedycyna Polska Spolka Akcyjna Logo Telemedycyna Polska Spolka Akcyjna Poland TMP
TISSUE REGENIX GROUP PLC Logo TISSUE REGENIX GROUP PLC United Kingdom TRX
TRELLUS HEALTH PLC Logo TRELLUS HEALTH PLC United Kingdom TRLS